James Kupiec has joined the company as Chief Clinical Development Officer (news posted on January 5 2021).
Create an alert
to follow the executive moves at Cassava Sciences.
Click on an executive to view his biography >
CVC Capital Partners has announced the acquisition of MedRisk (posted on Feb 24, 2021).
Jazz Pharmaceuticals has announced the acquisition of GW Pharmaceuticals (posted on Feb 4, 2021).
Nordic Capital has announced the acquisition of Advanz Pharma (posted on Feb 1, 2021).
RSS NEWS FEEDS | Cassava Sciences, Inc.
Cassava Sciences’ Phase 2b Clinical Results in Alzheimer’s Selected as Late-Breaking News at CTAD 2020 | Cassava Sciences, Inc.
Cassava Sciences Announces Final Results of a Phase 2b Clinical Study of Sumifilam in Patients with Alzheimer’s Disease | Cassava Sciences, Inc.
Cassava Sciences to Hold Conference Call on Monday, September 14, 2020 at 8:30 am ET | Cassava Sciences, Inc.
Cassava Sciences to Present at H.C. Wainwright’s 22nd Annual Global Investment Conference | Cassava Sciences, Inc.
Cassava Sciences on Wikipedia, Google News & Yahoo Finance
Cassava Sciences on LinkedIn, Twitter & YouTube
Cassava Sciences has 2,041 competitors including Pfizer (United States (USA)), Johnson & Johnson (United States (USA)) and Roche (Switzerland).
Contact by email its executives including Nadav Friedmann
Call Cassava Sciences at +1 512....
Learn about your clients' org charts. Understand their industries and their competitors.
View the executives' biographies. Contact the executives through our email platform.
Select key words to follow your clients. Receive alerts when executive movements happen.
File your clients in folders. Add private notes. Download our data in Excel on your PC.